P
Pharmala Biotech Holdings Inc
CNSX:MDMA
Pharmala Biotech Holdings Inc
CNSX:MDMA
Price:
0.1
CAD
Market Closed
Market Cap:
CA$10.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pharmala Biotech Holdings Inc
CNSX:MDMA
|
CA |
|
M
|
Mckesson Corp
BMV:MCK
|
US |
|
M
|
Marine & General Bhd
KLSE:M&G
|
MY |
|
M
|
Matachewan Consolidated Mines Ltd
XTSX:MCM.A
|
CA |
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
US |
|
D
|
Darco Water Technologies Ltd
SGX:BLR
|
SG |
|
Waverunner Capital Inc
OTC:CHMJF
|
CA |
|
Sonoro Gold Corp
XTSX:SGO
|
CA |
|
Mosa Industrial Corp
TWSE:4564
|
TW |
|
Rocket Doctor AI Inc
OTC:AIRDF
|
CA |
|
C
|
CaNickel Mining Ltd
OTC:CMLGF
|
CA |
Cash Flow Statement
Cash Flow Statement
Pharmala Biotech Holdings Inc
Pharmala Biotech Holdings Inc
Currency: CAD
| Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Change in Working Capital |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Operating Activities |
(0)
N/A
|
(1)
-124%
|
(1)
+40%
|
(0)
+43%
|
(0)
+8%
|
(0)
+30%
|
(0)
-48%
|
(0)
+5%
|
(0)
-35%
|
(0)
+20%
|
(0)
+8%
|
(1)
-79%
|
(1)
-25%
|
(1)
-4%
|
(1)
-39%
|
(1)
+12%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Cash from Investing Activities |
0
N/A
|
(1)
N/A
|
(1)
-49%
|
(1)
-7%
|
(1)
+22%
|
(1)
+20%
|
(1)
+24%
|
(0)
+13%
|
(0)
-7%
|
(0)
+5%
|
(0)
+50%
|
(0)
+14%
|
(1)
-599%
|
(1)
+12%
|
(1)
+21%
|
(1)
+20%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
2
|
2
|
2
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+384%
|
0
N/A
|
0
+37%
|
0
-15%
|
1
+262%
|
1
-3%
|
1
-4%
|
2
+210%
|
2
-32%
|
2
+1%
|
2
-3%
|
|
| Change in Cash | |||||||||||||||||
| Net Change in Cash |
2
N/A
|
(2)
N/A
|
(2)
+6%
|
(1)
+13%
|
(1)
+21%
|
(1)
+37%
|
(1)
+7%
|
(1)
+23%
|
(1)
-36%
|
(0)
+100%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-4%
|
(0)
+70%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(2)
-62%
|
(2)
+6%
|
(1)
+13%
|
(1)
+18%
|
(1)
+23%
|
(1)
+5%
|
(1)
+9%
|
(1)
-19%
|
(1)
+12%
|
(1)
+31%
|
(1)
-40%
|
(1)
-9%
|
(1)
+1%
|
(1)
-30%
|
(1)
+15%
|
|
Switch to:
Switch to:
See Also
Discover More
